These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 6203633)

  • 61. Opiate receptor-mediated inhibition of catecholamine release in primary cultures of bovine adrenal chromaffin cells.
    Saiani L; Guidotti A
    J Neurochem; 1982 Dec; 39(6):1669-76. PubMed ID: 6292366
    [No Abstract]   [Full Text] [Related]  

  • 62. Interactions of microtubule-active agents with nicotinic acetylcholine receptors. Relationship to their inhibition of catecholamine secretion by adrenal chromaffin cells.
    McKay DB; Aronstam RS; Schneider AS
    Mol Pharmacol; 1985 Jul; 28(1):10-6. PubMed ID: 2410767
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dynorphin and enkephalins in adrenal paraneurones. Opiates in the adrenal medulla.
    Lemaire S; Day R; Dumont M; Chouinard L; Calvert R
    Can J Physiol Pharmacol; 1984 Apr; 62(4):484-92. PubMed ID: 6203634
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Peptide E and its products, BAM 18 and Leu-enkephalin, in bovine adrenal medulla and cultured chromaffin cells: release in response to stimulation.
    Boarder MR; Evans C; Adams M; Erdelyi E; Barchas JD
    J Neurochem; 1987 Dec; 49(6):1824-32. PubMed ID: 3681299
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
    Mahapatra NR; Mahata M; Mahata SK; O'Connor DT
    J Hypertens; 2006 May; 24(5):895-904. PubMed ID: 16612252
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nicotinic receptor stimulation activates enkephalin release and biosynthesis in adrenal chromaffin cells.
    Eiden LE; Giraud P; Dave JR; Hotchkiss AJ; Affolter HU
    Nature; 1984 Dec 13-19; 312(5995):661-3. PubMed ID: 6150442
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Modulation of nicotinic receptor function by opiate recognition sites highly selective for Met5-enkephalin[Arg6Phe7].
    Costa E; Guidotti A; Hanbauer I; Saiani L
    Fed Proc; 1983 Sep; 42(12):2946-52. PubMed ID: 6884531
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of catecholamine release from the adrenal medulla by halothane. Site and mechanism of action.
    Göthert M; Dorn W; Loewenstein I
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep; 294(3):239-49. PubMed ID: 1004635
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Noncholinergic control of adrenal catecholamine secretion.
    Livett BG; Marley PD
    J Anat; 1993 Oct; 183 ( Pt 2)(Pt 2):277-89. PubMed ID: 7507911
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Co-release of enkephalins and precursors with catecholamines from the perfused cat adrenal gland in situ.
    Chaminade M; Foutz AS; Rossier J
    J Physiol; 1984 Aug; 353():157-69. PubMed ID: 6481622
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Choline stimulates nicotinic receptors on adrenal medullary chromaffin cells to induce catecholamine secretion.
    Holz RW; Senter RA
    Science; 1981 Oct; 214(4519):466-8. PubMed ID: 7291988
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Functional shift from muscarinic to nicotinic cholinergic receptors involved in inositol trisphosphate and cyclic GMP accumulation during the primary culture of adrenal chromaffin cells.
    Nakaki T; Sasakawa N; Yamamoto S; Kato R
    Biochem J; 1988 Apr; 251(2):397-403. PubMed ID: 2900002
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Exocytosis from a single rat chromaffin cell by cholinergic and peptidergic neurotransmitters.
    Chowdhury PS; Guo X; Wakade TD; Przywara DA; Wakade AR
    Neuroscience; 1994 Mar; 59(1):1-5. PubMed ID: 7910672
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cholinergic receptors and catecholamine secretion from adrenal chromaffin cells of the toad.
    Nassar-Gentina V; Luxoro M; Urbina N
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 100(3):495-500. PubMed ID: 1687546
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of ascorbic acid, dexamethasone, and insulin on the catecholamine and opioid peptide stores of cultured adrenal medullary chromaffin cells.
    Wilson SP; Kirshner N
    J Neurosci; 1983 Oct; 3(10):1971-8. PubMed ID: 6352871
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neuropeptide Y inhibits the nicotine-mediated release of catecholamines from bovine adrenal chromaffin cells.
    Higuchi H; Costa E; Yang HY
    J Pharmacol Exp Ther; 1988 Feb; 244(2):468-74. PubMed ID: 3346832
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enhancement of stimulation-evoked catecholamine release from cultured bovine adrenal chromaffin cells by forskolin.
    Morita K; Dohi T; Kitayama S; Koyama Y; Tsujimoto A
    J Neurochem; 1987 Jan; 48(1):243-7. PubMed ID: 3025364
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibitory effect of strychnine on acetylcholine receptor activation in bovine adrenal medullary chromaffin cells.
    Kuijpers GA; Vergara LA; Calvo S; Yadid G
    Br J Pharmacol; 1994 Oct; 113(2):471-8. PubMed ID: 7834198
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Time course of release of catecholamine and other granular contents from perifused adrenal chromaffin cells of guinea-pig.
    Ito S
    J Physiol; 1983 Aug; 341():153-67. PubMed ID: 6620178
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Substance P inhibits nicotinic activation of chromaffin cells.
    Livett BG; Kozousek V; Mizobe F; Dean DM
    Nature; 1979 Mar; 278(5701):256-7. PubMed ID: 423974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.